Comment on Draft Recommendation Statement and Draft Evidence Review: Primary Care–Based Interventions to Prevent Illicit Drug Use in Children, Adolescents, and Young Adults - US Preventive Services Task Force

Opportunity for Public Comment - US Preventive Services Task Force

Draft Recommendation Statement and Draft Evidence Review: Primary Care–Based Drug Use Prevention in Young People

Public Comment on Draft Recommendation Statement and Draft Evidence Review: Primary Care–Based Interventions to Prevent Illicit Drug Use in Children, Adolescents, and Young Adults The U.S. Preventive Services Task Force seeks comments on a draft recommendation statement and draft evidence review on primary care–based interventions to prevent illicit drug use in children, adolescents, and young adults. The Task Force found that more research is needed on how clinicians can help keep young people from starting to use drugs. The draft recommendation statement and draft evidence review are available for review and public comment from October 1, 2019 through October 28, 2019 here. The Draft Recommendation Statement and Draft Evidence Review Are Open to Public Comment

COMMENTING DETAILS

Public Comment Period: 10/1/19 - 10/28/19 Any visitor to the Task Force website can comment on any of the listed USPSTF draft documents. However, readers should note that the USPSTF writes these documents for researchers, primary care doctors, and other health care providers, using medical and scientific language as appropriate for these audiences.

DRAFT RECOMMENDATION SUMMARY

Population Recommendation Grade Children, adolescents, and young adults The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care–based behavioral counseling interventions to prevent or reduce illicit drug use, including nonmedical use of prescription drugs, in children, adolescents, and young adults. I

See the full draft recommendation statement

WHERE WE ARE IN THE PROCESS

Draft Research Plan Final Research Plan Draft Recommendation / Draft Evidence Review Final Recommendation / Evidence Summary